Cargando…
The Methyl-CpG-Binding Protein Mbd2 Regulates Susceptibility to Experimental Colitis via Control of CD11c(+) Cells and Colonic Epithelium
Methyl-CpG-binding domain-2 (Mbd2) acts as an epigenetic regulator of gene expression, by linking DNA methylation to repressive chromatin structure. Although Mbd2 is widely expressed in gastrointestinal immune cells and is implicated in regulating intestinal cancer, anti-helminth responses and colon...
Autores principales: | Jones, Gareth-Rhys, Brown, Sheila L., Phythian-Adams, Alexander T., Ivens, Alasdair C., Cook, Peter C., MacDonald, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033935/ https://www.ncbi.nlm.nih.gov/pubmed/32117307 http://dx.doi.org/10.3389/fimmu.2020.00183 |
Ejemplares similares
-
A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells
por: Cook, Peter C., et al.
Publicado: (2015) -
Dynamics of Colon Monocyte and Macrophage Activation During Colitis
por: Jones, Gareth-Rhys, et al.
Publicado: (2018) -
Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences
por: Günther, Katharina, et al.
Publicado: (2013) -
Methyl CpG binding domain protein 2 (MBD2) in inflammation
por: Lei, Qian, et al.
Publicado: (2022) -
High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology
por: Lan, Xun, et al.
Publicado: (2011)